UBE2C and small cell lung carcinoma: (Fig 9C) Vincristine, Cyclosporine, Methotrexate, Oxaliplatin, Topotecan and Cytarabine might be viewed as targeted drugs for the treatment of SCLC patients with high expression of UBE2C.